THE ANTICOAGULATION FORUM
4th Anticoagulation Boot Camp
January 14-15, 2016
Little American Hotel,
Downtown Salt Lake City, Utah
A compact 2-day conference providing comprehensive topics for anyone involved in anticoagulation care
Expert faculty will provide an interactive setting in a small group learning model with plenty of time for Q&A and dynamic discussion. Nursing and pharmacy CE credits will be provided.
Prior programs have sold out so register soon to secure your spot.
More details & registration links can be found at: www.acforumbootcamp.org
COMMUNITY OUTREACH VOLUNTEERS ATTEND BASEBALL GAME IN ATLANTA
July 17, 2015: Members of the Georgia Thrombosis Forum attended a game at the Atlanta Braves home stadium and broadcasted a short message encouraging individuals to educate themselves about thrombosis on a billboard for thousands of fans to see.
2016 SPRING PATIENT PROGRAM
Call to Action to Prevent Thrombosis:
Power to the Patient
Wednesday, April 6
4:30 PM - 8:30 PM
Joseph B. Martin Conference Center, Boston, MA
Our newly designed program exclusively for patients! This program is aimed at providing patients with the knowledge they need to prevent thrombosis and improve their cardiovascular health. Four experts in the field of Thrombosis Medicine will share updates from breakthrough research being done on serious conditions involving blood clots such as heart attack, stroke as a result of atrial fibrillation, pulmonary embolism, and deep vein thrombosis.
Three patient survivors of major thrombotic events will discuss everything from their symptoms and diagnosis through to their recovery and life after a thrombotic event. Reserve your seat now!
ANNOUNCING NATF'S 10TH ANNIVERSARY SIGNATURE EVENT
NATF's next Signature Event is scheduled to coincide with our 10th anniversary, and will take place on Thursday, March 10, 2016 at the Mandarin Oriental Hotel in Boston. Please mark your calendars for this special event!
DVT/PE TREATMENT OPTIONS
How do healthcare providers decide which treatments are the best option for their patients? Read this article to find out more about DVT/PE treatment goals, options, risks, and decision-making.
For many years, Warfarin was the only oral anticoagulant commonly used to treat blood clots. In the past five years, the FDA has approved four new oral anticoagulants for the treatment of DVT, PE, and SPAF. Find out the differences between the five FDA-approved oral anticoagulants. View the Chart.